본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Metabolic Syndrome as a Prognostic Factor in Papillary Thyroid Cancer Patients

이용수 5

영문명
Metabolic Syndrome as a Prognostic Factor in Papillary Thyroid Cancer Patients
발행기관
대한내분비외과학회
저자명
Hyeong Eun Jeong Ha Rim Ahn Sang Yull Kang Hyun Jo Youn Sung Hoo Jung
간행물 정보
『The Koreran journal of Endocrine Surgery』23권4호, 113~122쪽, 전체 10쪽
주제분류
의약학 > 면역학
파일형태
PDF
발행일자
2023.12.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: Metabolic syndrome (MetS) is considered a risk factor and poor prognostic factor for several cancers, and increases the risk of thyroid cancer and aggressiveness of papillary thyroid cancer (PTC). Here, we investigated the association between a poor prognosis in patients with PTC, and MetS. Methods: Patients diagnosed with PTC who underwent thyroidectomy between January 2013 and December 2015 at our institution were included (n=789). We divided patients into two groups according to the presence of MetS—defined as three or more of the following criteria: central obesity, hypertension, insulin resistance, low high-density lipoprotein cholesterol, and high triglycerides—identified by retrospective medical record review. We analyzed the clinicopathologic factors between the two groups, univariate and multivariate analyses were performed, and survival outcomes were analyzed by propensity score matching. Results: The mean patient age and median follow-up period were 47.0±11.2 years and 6.14 years, respectively; 119 patients (15.1%) were diagnosed with MetS. Significant differences between groups were identified regarding sex, age, operation extent, central neck dissection, lateral neck dissection, extrathyroidal extension (ETE), lateral lymph node metastasis, T stage, N stage, and radioactive iodine therapy. Old age, ETE, and MetS were identified as prognostic factors of recurrence-free survival (RFS) in the multivariate analysis. The 5-year RFS rates were 94.9% and 99.1% in the non-MetS and MetS groups, respectively, which was statistically significant (P=0.021). Conclusion: MetS is a prognostic factor for RFS among patients with PTC in our hospital.

목차

INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
REFERENCES

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Hyeong Eun Jeong,Ha Rim Ahn,Sang Yull Kang,Hyun Jo Youn,Sung Hoo Jung. (2023).Metabolic Syndrome as a Prognostic Factor in Papillary Thyroid Cancer Patients. The Koreran journal of Endocrine Surgery, 23 (4), 113-122

MLA

Hyeong Eun Jeong,Ha Rim Ahn,Sang Yull Kang,Hyun Jo Youn,Sung Hoo Jung. "Metabolic Syndrome as a Prognostic Factor in Papillary Thyroid Cancer Patients." The Koreran journal of Endocrine Surgery, 23.4(2023): 113-122

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제